Mesoblast
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 |
|---|---|---|
Revenue | $1,578 | $1,578 |
Gross Profit | -1,701 | -1,701 |
EBITDA | -9,454 | -9,454 |
EBIT | -9,992 | -9,992 |
Net Income | -23,967 | -23,967 |
Net Change In Cash | 1,578 | 1,578 |
Free Cash Flow | -10,380 | -10,566 |
Cash | 38,029 | 38,029 |
Basic Shares | 114,230 | 114,230 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $17,198 | $5,902 | $7,501 | $10,211 |
Gross Profit | 12,068 | -35,168 | -47,421 | -53,361 |
EBITDA | -73,659 | -56,077 | -58,550 | -76,573 |
EBIT | -80,059 | -57,972 | -62,657 | -80,953 |
Net Income | -102,142 | -87,956 | -81,889 | -91,347 |
Net Change In Cash | 17,198 | 5,902 | 7,501 | 10,211 |
Free Cash Flow | -50,684 | -48,789 | -63,583 | -66,014 |
Cash | 161,158 | 62,563 | 70,920 | 60,034 |
Basic Shares | 120,779 | 98,670 | 83,926 | 68,286 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.04 |
2025-03-31 | $0 |
2024-12-31 | -$0.04 |
